“Evolving Regulatory Positions and Legacy Data Challenges: A Case Study of Fludioxonil’s Unknown Metabolite Fraction MF2 in European Active Ingredient Renewal”, AJEER, vol. 1, no. 1, pp. 1–7, Oct. 2025, doi: 10.70844/ajeer.2025.1.7.